The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson’s disease

The department studies the biological bases and molecular mechanisms of brain aging and brain pathologies, including neurodegenerative, cerebrovascular, and neuroinflammatory diseases. In the same way, it addresses the study of brain circuits and synaptic processes involved in neuropsychiatric disorders such as depression and schizophrenia.